EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
about
Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivoSKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling.Zebrafish Discoveries in Cancer Epigenetics.EZH2 overexpression is associated with poor prognosis in patients with gliomaInhibitor of differentiation 4 (ID4): From development to cancerMetabolomic profiling for the identification of novel diagnostic markers in prostate cancer.Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.Mutations and deletions of PRC2 in prostate cancer.H3K27me3 is an Epigenetic Mark of Relevance in Endometriosis.Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.The Id-protein family in developmental and cancer-associated pathways.Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growthID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.miRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis.Induction of Lumen Formation in a Three-dimensional Model of Mammary Morphogenesis by Transcriptional Regulator ID4: ROLE OF CaMK2D IN THE EPIGENETIC REGULATION OF ID4 GENE EXPRESSION.Multiple regulatory aspects of histone methyltransferase EZH2 in Pb-induced neurotoxicity.EZH2-mediated suppression of lncRNA-LET promotes cell apoptosis and inhibits the proliferation of post-burn skin fibroblasts.Inhibition of enhancer of zeste homolog 2 increases the expression of p16 and suppresses the proliferation and migration of ovarian carcinoma cells in vitro and in vivo.EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer.
P2860
Q33865244-BDB5C15B-E4E1-4821-AAC1-7415ED8274B8Q35176138-0395DAA0-9642-45A0-A1BE-42385B92723FQ35955196-A93190F1-0146-42B8-BF9E-BB7E49AC36C7Q37437329-2E3B70F7-9DCB-421C-9CF7-BC91D6CBDDE3Q37564360-413403DC-5F3F-42C3-BE6A-458D494A4D9FQ37651410-F3A6D9E8-FB11-4240-BF1B-A1984A0B2946Q37702313-AE24D3DB-76F8-4ED3-A8B1-90741AF415D3Q38289940-986A5F1D-BA7F-4BF9-A8C4-3955E7BB1C8EQ38547110-41C0451C-7925-4800-BDDF-3D99A8FFDABEQ38714216-340273D3-FC03-43DB-8473-68F9AB3FC25DQ38783694-BD709809-28BB-4BE3-8C6E-41C8AC7831DFQ38893487-0056CB1E-E341-4125-B427-1D17B80F7080Q38898841-59EC5AE5-654B-4F05-969A-5B6AC698A692Q39103288-BB2476C0-B4E8-4D2B-AAF0-E23A60F4BC71Q39529516-FE8CFDA0-CF2C-4346-9E30-083FAA952B8FQ41554763-23965AC8-9030-44CA-8943-04985C93745FQ41817629-191BD0D7-7ECC-43D6-BEE0-B1D84803E780Q42110876-E22FA141-13DB-426B-A189-45D4F8BC2CDDQ43962104-AF0338E9-DC41-48CB-9602-6BCB2D71A749Q49379781-9B6ADE08-CF21-48C4-AE9D-872269AABF92Q49777893-E4AD4D09-D96E-4BAF-BFBB-8B43DA57BB63Q50115221-50F8F6F8-0CF9-48C9-9388-B31B0B0BC99BQ53223003-633D33CA-C2F5-4024-87F2-0199DC2F16B1
P2860
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
@en
type
label
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
@en
prefLabel
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.
@en
P2093
Jaideep Chaudhary
Pankaj Sharma
Swathi Chinaranagari
P2860
P304
P356
10.18632/ONCOTARGET.2262
P407
P577
2014-08-01T00:00:00Z